A detailed history of Citigroup Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 70,682 shares of IDYA stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,682
Previous 46,077 53.4%
Holding current value
$1.64 Million
Previous $1.62 Million 38.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.37 - $43.05 $747,253 - $1.06 Million
24,605 Added 53.4%
70,682 $2.24 Million
Q2 2024

Aug 12, 2024

SELL
$34.37 - $43.46 $5.47 Million - $6.91 Million
-159,039 Reduced 77.54%
46,077 $1.62 Million
Q1 2024

May 10, 2024

BUY
$34.2 - $47.13 $3.95 Million - $5.44 Million
115,418 Added 128.67%
205,116 $9 Million
Q4 2023

Feb 09, 2024

BUY
$24.59 - $35.83 $846,977 - $1.23 Million
34,444 Added 62.34%
89,698 $3.19 Million
Q3 2023

Nov 09, 2023

BUY
$21.07 - $29.77 $41,444 - $58,557
1,967 Added 3.69%
55,254 $1.49 Million
Q2 2023

Aug 10, 2023

SELL
$13.33 - $25.53 $678,137 - $1.3 Million
-50,873 Reduced 48.84%
53,287 $1.25 Million
Q1 2023

May 11, 2023

BUY
$13.49 - $18.72 $458,970 - $636,910
34,023 Added 48.51%
104,160 $1.43 Million
Q4 2022

Feb 09, 2023

SELL
$14.47 - $18.17 $511,847 - $642,727
-35,373 Reduced 33.53%
70,137 $1.27 Million
Q3 2022

Nov 10, 2022

SELL
$9.24 - $15.79 $905,409 - $1.55 Million
-97,988 Reduced 48.15%
105,510 $1.57 Million
Q2 2022

Aug 10, 2022

BUY
$8.28 - $13.88 $1.5 Million - $2.52 Million
181,519 Added 825.87%
203,498 $2.81 Million
Q1 2022

May 12, 2022

SELL
$11.18 - $24.02 $785,652 - $1.69 Million
-70,273 Reduced 76.18%
21,979 $246,000
Q4 2021

Feb 10, 2022

BUY
$20.95 - $26.88 $1.4 Million - $1.8 Million
67,028 Added 265.73%
92,252 $2.18 Million
Q3 2021

Nov 10, 2021

BUY
$17.26 - $27.08 $435,366 - $683,065
25,224 New
25,224 $643,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.12B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.